MBX Biosciences, Inc. financial data

Symbol
MBX on Nasdaq
Location
Carmel, IN
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 12 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2515% %
Debt-to-equity 4.2% %
Return On Equity -29% % 60%
Return On Assets -28% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 47,510,243 shares 42%
Common Stock, Shares, Outstanding 44,927,953 shares 34%
Entity Public Float $237,327,692 USD -24%
Common Stock, Value, Issued $6,000 USD 20%
Weighted Average Number of Shares Outstanding, Basic 36,506,092 shares 243%
Weighted Average Number of Shares Outstanding, Diluted 36,506,092 shares 243%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $79,159,000 USD 38%
General and Administrative Expense $18,896,000 USD 75%
Operating Income (Loss) $98,055,000 USD -44%
Net Income (Loss) Attributable to Parent $86,971,000 USD -40%
Earnings Per Share, Basic -2.38 USD/shares 59%
Earnings Per Share, Diluted -2.38 USD/shares 59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $75,289,000 USD 53%
Marketable Securities, Current $298,416,000 USD 40%
Cash, Cash Equivalents, and Short-term Investments $373,700,000 USD 43%
Other Assets, Current $861,000 USD 7.2%
Assets, Current $381,539,000 USD 43%
Property, Plant and Equipment, Net $2,735,000 USD 153%
Operating Lease, Right-of-Use Asset $487,000 USD 309%
Other Assets, Noncurrent $383,000 USD 666%
Assets $385,144,000 USD 43%
Accounts Payable, Current $2,977,000 USD -44%
Accrued Liabilities, Current $12,346,000 USD 123%
Liabilities, Current $15,495,000 USD 40%
Operating Lease, Liability, Noncurrent $424,000 USD
Liabilities $15,921,000 USD 44%
Accumulated Other Comprehensive Income (Loss), Net of Tax $286,000 USD 420%
Retained Earnings (Accumulated Deficit) $224,476,000 USD -63%
Stockholders' Equity Attributable to Parent $369,223,000 USD 43%
Liabilities and Equity $385,144,000 USD 43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $22,678,000 USD -112%
Net Cash Provided by (Used in) Financing Activities $183,000 USD
Net Cash Provided by (Used in) Investing Activities $3,226,000 USD -79%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 44,927,953 shares 34%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $19,448,000 USD -497%
Deferred Tax Assets, Valuation Allowance $67,794,000 USD 64%
Deferred Tax Assets, Gross $68,070,000 USD 63%
Depreciation $248,000 USD 1.6%
Payments to Acquire Property, Plant, and Equipment $30,000 USD -89%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $86,740,000 USD -40%
Property, Plant and Equipment, Gross $3,405,000 USD 127%
Operating Lease, Liability, Current $172,000 USD 0.58%
Deferred Tax Assets, Operating Loss Carryforwards $35,463,000 USD 138%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $6,727,000 USD 55%
Operating Lease, Payments $200,000 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%